ESR1 and hepatocellular carcinoma: Altogether, these findings provide support for the notion that ERA can suppress HCC cell invasion via altering ERA/circRNA‐SMG1.72/miR‐141‐3p/GSN axis and this signalling pathway can be considered as a target for suppression of HCC progression.166